LASA — Lasa Supergenerics Income Statement
0.000.00%
Last trade - 00:00- IN₹606.22m
- IN₹619.60m
- IN₹1.42bn
Annual income statement for Lasa Supergenerics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | C2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2,024 | 1,371 | 1,296 | 1,043 | 1,424 |
| Cost of Revenue | |||||
| Gross Profit | 900 | 400 | 164 | 219 | 363 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1,710 | 1,427 | 1,676 | 1,216 | 1,642 |
| Operating Profit | 314 | -55.6 | -380 | -173 | -217 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 295 | -61.4 | -423 | -191 | -194 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 228 | -53.3 | -386 | -217 | -148 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 228 | -53.3 | -386 | -217 | -148 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 228 | -53.3 | -386 | -217 | -148 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 5.6 | -0.056 | -5.22 | -3.2 | -0.914 |
| Dividends per Share |